MENU
ICLR
AS OF
Feb 3, 04:59 PM (EDT)
Price
$168.49
Change
-$19.22 (-10.24%)
Capitalization
13.64B
22 days until earnings call
Intraday BUY SELL Signals

ICLR Stock ICON (ICLR, $180.15) Moving Average Convergence Divergence (MACD) Histogram turned negative on January 12, 2026

A.I.dvisor
at Tickeron.com
Loading...
ICLR - ICON plc
MACD signal
Bearish Trend
Odds of DOWN Trend
Tickeron
MACD signal
Price: $180.15
Daily change: -$1.23 (-0.68%)
Daily volume: 887K
Capitalization: $13.8B
Industry: Medical Specialties

This is a Bearish indicator signaling ICLR's price could decline from here. Traders may explore shorting the stock or put options. A.I. dvisor identified 44 similar cases where ICLR's MACD histogram became negative, and of them led to successful outcomes. Odds of Success:

ICLR in +0.68% Uptrend, growing for three consecutive days on January 27, 2026

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where ICLR advanced for three days, in of 311 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis
Bearish Trend Analysis

The 10-day RSI Indicator for ICLR moved out of overbought territory on January 08, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 37 similar instances where the indicator moved out of overbought territory. In of the 37 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 65 cases where ICLR's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Momentum Indicator moved below the 0 level on January 30, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ICLR as a result. In of 92 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for ICLR turned negative on January 12, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at .

ICLR moved below its 50-day moving average on January 30, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ICLR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

ICLR broke above its upper Bollinger Band on January 05, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. ICLR’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.461) is normal, around the industry mean (12.127). P/E Ratio (24.069) is within average values for comparable stocks, (122.497). Projected Growth (PEG Ratio) (1.393) is also within normal values, averaging (1.899). ICLR has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.016). P/S Ratio (1.767) is also within normal values, averaging (12.541).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ICLR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.

View a ticker or compare two or three
ICLR
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ICLR showed earnings on October 22, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a provider of clinical research and development services

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
South County Business Park
Phone
+353 12912000
Employees
41100
Web
https://www.iconplc.com